Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Griseofulvin | hsa00010 | Glycolysis / Gluconeogenesis | 1.18E-02 | 2 | P60174, P06744 | TPI1, GPI | More | | Griseofulvin | hsa00053 | Ascorbate and aldarate metabolism | 1.80E-02 | 2 | P51648, Q9UEF7 | ALDH3A2, KL | More | | Griseofulvin | hsa00310 | Lysine degradation | 4.27E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Griseofulvin | hsa00515 | Mannose type O-glycan biosynthesis | 4.57E-02 | 1 | O75072 | FCMD | More | | Griseofulvin | hsa00561 | Glycerolipid metabolism | 4.36E-03 | 3 | O14494, P51648, P23743 | PLPP1, ALDH3A2, DGKA | More | | Griseofulvin | hsa00600 | Sphingolipid metabolism | 4.77E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Griseofulvin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.42E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Griseofulvin | hsa00983 | Drug metabolism - other enzymes | 4.77E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Griseofulvin | hsa01200 | Carbon metabolism | 1.99E-02 | 2 | P06744, P60174 | GPI, TPI1 | More | | Griseofulvin | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.90E-02 | 3 | P17252, P10415, Q9NRA1 | PRKCA, BCL2, PDGFC | More | | Griseofulvin | hsa01524 | Platinum drug resistance | 4.02E-02 | 4 | Q13315, P10415, Q13489, P43246 | ATM, BCL2, BIRC3, MSH2 | More | | Griseofulvin | hsa03013 | RNA transport | 2.82E-04 | 14 | P52298, O14893, P61326, Q7Z3B4, P35658, Q99567, Q96D46, Q14152, O75822, P78345, Q9BZI7, Q9Y6A5, Q06787, P51114 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, NUP88, NMD3, EIF3A, EIF3J, RPP38, UPF3B, TACC3, FMR1, FXR1 | More | | Griseofulvin | hsa03040 | Spliceosome | 1.45E-04 | 11 | Q14562, O43143, O60508, P26368, P52298, Q13595, Q07955, Q01130, P84103, Q13243, P11142 | DHX8, DHX15, CDC40, U2AF2, NCBP2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8 | More | | Griseofulvin | hsa04020 | Calcium signaling pathway | 2.09E-02 | 5 | Q16566, P17252, P25116, P0DP23, Q9NRA1 | CAMK4, PRKCA, F2R, CALM1, PDGFC | More | | Griseofulvin | hsa04064 | NF-kappa B signaling pathway | 3.04E-03 | 8 | P10415, Q13489, P25963, P51617, Q13546, Q9UDY8, Q13315, O75293 | BCL2, BIRC3, NFKBIA, IRAK1, RIPK1, MALT1, ATM, GADD45B | More | | Griseofulvin | hsa04071 | Sphingolipid signaling pathway | 2.95E-03 | 6 | P17252, P21453, Q13362, Q9BX95, P10415, P01042 | PRKCA, S1PR1, PPP2R5C, SGPP1, BCL2, KNG1 | More | | Griseofulvin | hsa04072 | Phospholipase D signaling pathway | 1.06E-02 | 5 | P25116, P17252, O14494, P23743, Q9NRA1 | F2R, PRKCA, PLPP1, DGKA, PDGFC | More | | Griseofulvin | hsa04141 | Protein processing in endoplasmic reticulum | 2.77E-02 | 5 | P27824, P30101, P60604, P11142, P08238 | CANX, PDIA3, UBE2G2, HSPA8, HSP90AB1 | More | | Griseofulvin | hsa04145 | Phagosome | 3.68E-05 | 9 | Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443, P27824 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, CANX | More | | Griseofulvin | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Griseofulvin | hsa04217 | Necroptosis | 3.69E-05 | 8 | P01568, Q13489, Q13546, P42224, P08238, Q6FI13, P10415, O43633 | IFNA21, BIRC3, RIPK1, STAT1, HSP90AB1, H2AC18; H2AC19, BCL2, CHMP2A | More | | Griseofulvin | hsa04371 | Apelin signaling pathway | 1.12E-03 | 9 | P62873, P63218, P50151, Q13370, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Griseofulvin | hsa04520 | Adherens junction | 8.77E-03 | 4 | Q13485, P84022, O95863, Q15223 | SMAD4, SMAD3, SNAI1, PVRL1 | More | | Griseofulvin | hsa04540 | Gap junction | 5.44E-03 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | Griseofulvin | hsa04613 | Neutrophil extracellular trap formation | 1.23E-03 | 5 | P11215, Q13547, P58876, Q16778, O60814 | ITGAM, HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Griseofulvin | hsa04620 | Toll-like receptor signaling pathway | 7.24E-03 | 5 | P51617, Q13546, P01568, P42224, P25963 | IRAK1, RIPK1, IFNA21, STAT1, NFKBIA | More | | Griseofulvin | hsa04621 | NOD-like receptor signaling pathway | 4.54E-02 | 7 | P08238, P42224, P01568, P25963, Q13489, P10415, Q13546 | HSP90AB1, STAT1, IFNA21, NFKBIA, BIRC3, BCL2, RIPK1 | More | | Griseofulvin | hsa04623 | Cytosolic DNA-sensing pathway | 4.52E-05 | 3 | P01568, Q13546, P25963 | IFNA21, RIPK1, NFKBIA | More | | Griseofulvin | hsa04659 | Th17 cell differentiation | 1.64E-02 | 5 | P19174, P84022, Q13485, P08238, P07766 | PLCG1, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Griseofulvin | hsa04664 | Fc epsilon RI signaling pathway | 2.35E-02 | 3 | P07948, P19174, P09917 | LYN, PLCG1, ALOX5 | More | | Griseofulvin | hsa04666 | Fc gamma R-mediated phagocytosis | 2.81E-02 | 4 | P23528, O14494, P14598, P17252 | CFL1, PLPP1, NCF1, PRKCA | More | | Griseofulvin | hsa04710 | Circadian rhythm | 1.79E-02 | 1 | O15516 | CLOCK | More | | Griseofulvin | hsa04720 | Long-term potentiation | 2.05E-02 | 3 | P17252, Q16566, P0DP23 | PRKCA, CAMK4, CALM1 | More | | Griseofulvin | hsa04724 | Glutamatergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Griseofulvin | hsa04725 | Cholinergic synapse | 8.04E-03 | 4 | P17252, P62873, Q16566, P10415 | PRKCA, GNB1, CAMK4, BCL2 | More | | Griseofulvin | hsa04727 | GABAergic synapse | 4.43E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Griseofulvin | hsa04744 | Phototransduction | 8.61E-05 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Griseofulvin | hsa04915 | Estrogen signaling pathway | 2.99E-02 | 1 | P19012 | KRT15 | More | | Griseofulvin | hsa04916 | Melanogenesis | 2.90E-02 | 3 | P0DP23, Q9UJU2, P17252 | CALM1, LEF1, PRKCA | More | | Griseofulvin | hsa04925 | Aldosterone synthesis and secretion | 3.91E-02 | 3 | P0DP23, P17252, Q16566 | CALM1, PRKCA, CAMK4 | More | | Griseofulvin | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 6.76E-04 | 3 | P20020, Q9UEF7, P17252 | ATP2B1, KL, PRKCA | More | | Griseofulvin | hsa04972 | Pancreatic secretion | 2.68E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Griseofulvin | hsa04975 | Fat digestion and absorption | 4.57E-02 | 1 | O14494 | PLPP1 | More | | Griseofulvin | hsa05032 | Morphine addiction | 4.43E-02 | 3 | P63218, P50151, P43250 | GNG5, GNG10, GRK6 | More | | Griseofulvin | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Griseofulvin | hsa05132 | Salmonella infection | 3.59E-07 | 13 | P51617, P25963, P08238, Q9UJU2, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q13509, P68371 | IRAK1, NFKBIA, HSP90AB1, LEF1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Griseofulvin | hsa05140 | Leishmaniasis | 4.05E-03 | 6 | P14598, P42224, P25963, P29350, P51617, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, IRAK1, NCF4 | More | | Griseofulvin | hsa05145 | Toxoplasmosis | 1.95E-02 | 6 | P51617, P25963, P10415, Q13489, P42224, P11142 | IRAK1, NFKBIA, BCL2, BIRC3, STAT1, HSPA8 | More | | Griseofulvin | hsa05150 | Staphylococcus aureus infection | 2.98E-04 | 5 | P19012, Q14532, P16109, P59665, P59666 | KRT15, KRT32, SELP, DEFA1; DEFA1B, DEFA3 | More | | Griseofulvin | hsa05152 | Tuberculosis | 2.49E-05 | 10 | Q13488, P0DP23, P42224, P48382, P25208, O60603, P10415, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, STAT1, RFX5, NFYB, TLR2, BCL2, IFNA21, MALT1, IRAK1 | More | | Griseofulvin | hsa05162 | Measles | 4.50E-03 | 8 | P51617, P01568, P25963, P42224, P14784, P10747, P11142, P10415 | IRAK1, IFNA21, NFKBIA, STAT1, IL2RB, CD28, HSPA8, BCL2 | More | | Griseofulvin | hsa05166 | Human T-cell leukemia virus 1 infection | 1.77E-02 | 8 | P27824, P30279, P21796, P84022, Q13485, P07766, Q92830, P06746 | CANX, CCND2, VDAC1, SMAD3, SMAD4, CD3E, KAT2A, POLB | More | | Griseofulvin | hsa05168 | Herpes simplex virus 1 infection | 5.65E-04 | 14 | P25963, P01568, P42224, Q07955, Q01130, Q13243, Q13489, P51617, Q13398, Q9NR11, P17097, P17038, Q03923, P10415 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, ZNF211, ZNF302, ZNF7, ZNF43, ZNF85, BCL2 | More | | Griseofulvin | hsa05170 | Human immunodeficiency virus 1 infection | 4.91E-06 | 13 | P62873, P0DP23, P17252, Q13546, Q14643, P01568, P51617, P25963, O60603, Q13315, P23528, P10415, Q9Y6Q5 | GNB1, CALM1, PRKCA, RIPK1, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, CFL1, BCL2, AP1M2 | More | | Griseofulvin | hsa05200 | Pathways in cancer | 2.19E-05 | 27 | P04628, Q13751, P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P84022, Q13485, P20585, P14923, P30279, P10415, Q13489, Q12778, P25116, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784, P01042 | WNT1, LAMB3, HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, MSH3, JUP, CCND2, BCL2, BIRC3, FOXO1, F2R, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB, KNG1 | More | | Griseofulvin | hsa05202 | Transcriptional misregulation in cancer | 1.65E-03 | 15 | Q12778, Q15532, Q13315, P14780, P27930, P14923, P11215, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0, Q13547, P12980 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, ITGAM, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B, HDAC1, LYL1 | More | | Griseofulvin | hsa05203 | Viral carcinogenesis | 6.95E-04 | 10 | P06746, Q92830, P07948, P30279, P29083, Q13547, P58876, Q93079, Q16778, O60814 | POLB, KAT2A, LYN, CCND2, GTF2E1, HDAC1, H2BC5, H2BC9, HIST2H2BE, H2BC12 | More | | Griseofulvin | hsa05205 | Proteoglycans in cancer | 1.67E-02 | 9 | Q13009, Q14643, O75369, P14780, P17252, O60603, P04628, Q13635, P08962 | TIAM1, ITPR1, FLNB, MMP9, PRKCA, TLR2, WNT1, PTCH1, CD63 | More | | Griseofulvin | hsa05214 | Glioma | 2.90E-02 | 3 | P0DP23, Q16566, P17252 | CALM1, CAMK4, PRKCA | More | | Griseofulvin | hsa05215 | Prostate cancer | 6.15E-03 | 5 | P10415, Q9UJU2, Q12778, Q9NRA1, P08238 | BCL2, LEF1, FOXO1, PDGFC, HSP90AB1 | More | | Griseofulvin | hsa05231 | Choline metabolism in cancer | 5.44E-03 | 4 | Q9NRA1, P23743, O14494, P17252 | PDGFC, DGKA, PLPP1, PRKCA | More | | Griseofulvin | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | | Griseofulvin | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.91E-02 | 1 | P54284 | CACNB3 | More | | |